Mission Statement
History
Directors and Trustees
Scientific Advisory Board
Corporate Sponsors
Newsletters
News
Press Room
Home
>
About the Hirshberg Foundation For Pancreatic Cancer Research
>
News
News
Think Tank of Top Researchers and Physicians Presented Advancements in Pancreatic Cancer Research at 8th Annual Agi Hirshberg Symposium on Pancreatic Cancer
UCLA study pinpoints types of bacteria in saliva associated with pancreatic cancer
Steve Jobs Dies of Pancreatic Cancer
Nobel Prize Winner Dies of Pancreatic Cancer
Metformin continues to prove viability
Pancreatic cancer, targeted drugs in comparison with phytochemicals
Hirshberg Foundation Awards and Grants 2010
Hirshberg Foundation funds UCLA study of fructose in pancreatic cancer
Small advances against pancreatic cancer
Howard A. Reber, M.D., Distinguished Professor of Surgery, UCLA School of Medicine
Discovery of a Potential New Drug against Pancreatic Cancer
UCLA Saliva Study for Pancreatic Cancer
GVAX pancreatic cancer vaccine gains FDA orphan-drug status
UCLA–Veterans Affairs team develops new tool to help guide pancreatic cyst treatment
Predicting Prognosis and Treatment Response in Subset of Pancreatic Cancer Patients
UCLA Surgeons Identify Molecular Pathway That May Help Target Future Therapies Againist Tumor Angiogenesis
Metformin reduces the growth of pancreatic cancer
Risk of Pancreatic Cancer Linked to Variation in Gene that Determines Blood Type
Pancreatic Cancer Prevention
UCLA Center for Excellence in Pancreatic Diseases launches new website
Hirshberg Foundation Awards and Grants 2008-2009
Pain Management Update
Phase One Clinical Trial
Hirshberg Foundation Awards and Grants 2007-2008
NIH grants awarded to UCLA researchers
Cancer of the Pancreas Screening Study at UCLA
In Memory of Patrick Swayze
Patrick Swayze Hard at Work
COX-2 inhibitors delay pancreatic cancer precursors in mice
Last Lecture Author, Randy Pausch Dies at 47